Results 31 to 40 of about 260,154 (263)

Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study

Thorax, 2022
Introduction Malignant mesothelioma (MM) is an aggressive cancer that primarily arises from the pleura (MPM) or peritoneum (MPeM), mostly due to asbestos exposure. This study reviewed the Dutch population-based incidence, treatment and survival since the
J. V. van Kooten, R. Belderbos, J. H. von der Thüsen, M. Aarts, C. Verhoef, J. A. Burgers, P. Baas, A. Aalbers, A. Maat, J. Aerts, R. Cornelissen, E. Madsen   +11 more
semanticscholar   +1 more source

Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma

JAMA Network Open, 2021
This cohort study examines the clinical efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced malignant peritoneal mesothelioma.
K. Raghav, Suyu Liu, M. Overman, A. Morani, Anneleis Willette, K. Fournier, G. Varadhachary   +6 more
semanticscholar   +1 more source

Extraperitoneal parastomal metastasis of malignant peritoneal mesothelioma

, 2021
A 75-year-old man was referred to surgical outpatient department with what was thought to be a parastomal hernia. Through further investigations with CT and biopsy, it was identified that the parastomal mass was metastatic peritoneal mesothelioma in the ...
Ho, YM, Ruhnke, M, Hoff, J, Castrisos, G
core   +1 more source

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

BMC Cancer, 2021
Background Standard treatment for malignant peritoneal mesothelioma has not been established, and systemic chemotherapy is administered according to malignant pleural mesothelioma. We previously reported the efficacy of cisplatin plus pemetrexed as first-
R. Kitadai, T. Shimoi, K. Sudo, E. Noguchi, Y. Nagata, R. Sawada, A. Takashima, N. Boku, K. Yonemori   +8 more
semanticscholar   +1 more source

Medical-type peritoneal mesothelioma leading to death two months after onset of fever of unknown origin

Radiology Case Reports, 2022
In malignant mesotheliomas, cases involving the peritoneum as the primary site are rare, accounting for approximately 10% of all mesothelioma cases. We report a case of medical-type peritoneal mesothelioma leading to death 2 months after the onset of ...
Kosuke Ishizuka, MD, Takanori Uehara, MD, PhD, Makoto Arai, MD, PhD, Junichiro Ikeda, MD, PhD, Yuta Hirose, MD, PhD, Masatomi Ikusaka, MD, PhD   +5 more
doaj   +1 more source

Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2023
Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM).
D. Ettinger, Douglas E. Wood, J. Stevenson, D. Aisner, W. Akerley, J. R. Bauman, A. Bharat, D. S. Bruno, Joe Y Chang, L. Chirieac, Malcolm DeCamp, T. Dilling, Jonathan Dowell, Gregory A. Durm, S. Gettinger, T. Grotz, M. Gubens, A. Hegde, R. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, C. Lovly, F. Maldonado, E. Massarelli, D. Morgensztern, T. Mullikin, Thomas Ng, G. Otterson, S. Patel, T. Patil, Patricio M. Polanco, Gregory Riely, J. Riess, Theresa A. Shapiro, Aditi P. Singh, A. Tam, T. Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin H Yau, K. Gregory, M. Hughes   +42 more
semanticscholar   +1 more source

Bilateral Pleural Mesothelioma In Situ and Peritoneal Mesothelioma In Situ Associated With BAP1 Germline Mutation: A Case Report

JTO Clinical and Research Reports, 2022
Mesothelioma in situ is a recently described precursor to invasive mesothelioma. Thus far, all cases in the literature have involved one pleural cavity or the peritoneal cavity. We describe a patient with biopsy-proven mesothelioma in situ involving both
Alyssa MacLean, MD, Andrew Churg, MD, PhD, Scott Thomas Johnson, MD, MSc, FRCSC   +2 more
doaj   +1 more source

STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy

JCO Precision Oncology, 2021
Introduction ALK fusions were first described by Morris et al in 1994. Several studies have reported genetic alterations of the ALK gene in various tumor types since then, consisting of mutations, amplifications, and fusions.
V. Gerthofer, Alexander Scheiter, F. Lüke, F. Keil, K. Utpatel, Laura-Maria-Giovanna Pöhmerer, J. Seitz, C. Niessen, A. Ignatov, W. Dietmaier, D. Calvisi, M. Evert, O. Ortmann, S. Seitz   +13 more
semanticscholar   +1 more source

Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells. [PDF]

, 2012
Mesothelial cells are critical in the pathogenesis of post-surgical intraabdominal adhesions as well as in the deterioration of the peritoneal membrane associated with long-term peritoneal dialysis.
Elfriede Noessner, Susan Notohamiprodjo, Pankaj Goyal, Sauter, M., Sitter, T., Sitter, Thomas, Markus Wörnle, Andrea Ribeiro, Peter J. Nelson (168215), Thomas Sitter, Matthias Sauter (168187), Wolfgang Siess, Wolfgang Siess (168198), Susanne Himmelein, Nelson, P.J., Himmelein, Susanne, Thomas Sitter (168211), Goyal, P., Sauter, Matthias, Susanne Himmelein (168206), Nelson, Peter J., Markus Wörnle (168201), Susan Notohamiprodjo (168192), Ribeiro, A., Notohamiprodjo, Susan, Elfriede Noessner (146689), Noessner, Elfriede, Wörnle, Markus, Djafarzadeh, Roghieh, Roghieh Djafarzadeh, Matthias Sauter, Nößner, E., Andrea Ribeiro (168203), Roghieh Djafarzadeh (88033), Himmelein, S., Peter J Nelson, Wörnle, M., Goyal, Pankaj, Ribeiro, Andrea, Djafarzadeh, R., Notohamiprodjo, S., Pankaj Goyal (156516), Siess, W., Siess, Wolfgang   +43 more
core   +1 more source

Malignant Peritoneum Mesothelioma with Hepatic Involvement: A Single Institution Experience in 5 Patients and Review of the Literature

Gastroenterology Research and Practice, 2016
Malignant peritoneal mesothelioma with invasion of the liver is an invariably fatal disease. We aimed to clarify the characteristics of malignant peritoneal mesothelioma cases with liver involvement. The clinical presentation, computed tomography images,
Shan-shan Su, Guo-qi Zheng, Ya-gang Liu, Yue-feng Chen, Zhao-wei Song, Shu-jing Yu, Ning-ning Sun, Yu-xin Yang   +7 more
doaj   +1 more source